Library / Laws / 115th Congress / Senate Bills / S. 3420
S. 3420
To require the Food and Drug Administration to prioritize the promotional materials for drugs for serious, life-threatening diseases or conditions or substance use disorders, especially opioid drugs and drugs for medication-assisted treatment, in considering whether promotional materials are false or misleading.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2018-09-06 | 1.3K | ⠃⠗⠋ |